Straumann Holding AG
SIX:STMN
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
84.9
134.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Straumann Holding AG
Straumann Holding AG, headquartered in Basel, Switzerland, has carved a niche in the dental industry by consistently positioning itself at the forefront of innovation and quality. Established in 1954, the company originally delved into alloys used in timepieces and measurement instruments, but it soon pivoted towards medical technology beneath the visionary leadership that embraced research and development. Today, Straumann is a formidable player in the sphere of dental implants, prosthetics, and orthodontic solutions. The company is driven by a simple yet impactful mission: to provide dentists and their patients with the tools and treatments necessary to restore smiles and enhance oral health. Through a robust network of subsidiaries and partners worldwide, Straumann's reach extends to more than 100 countries, facilitating both the manufacturing and distribution of its products on a global scale.
The engine behind the company’s success is its dedication to innovation, customer focus, and education. By investing heavily in R&D, Straumann develops cutting-edge products that address the evolving needs of patients and dental professionals. The company's revenue streams primarily originate from the sale of dental implants, restorative products, and digital equipment, making it a major player in both the premium and value segments of the market. Beyond its product offerings, Straumann thrives by training dental professionals through its comprehensive educational initiatives, ensuring its clients are well-prepared to deliver the highest standard of care. This synergistic approach not only amplifies customer loyalty but also firmly establishes Straumann as a trusted leader in the industry.
Straumann Holding AG, headquartered in Basel, Switzerland, has carved a niche in the dental industry by consistently positioning itself at the forefront of innovation and quality. Established in 1954, the company originally delved into alloys used in timepieces and measurement instruments, but it soon pivoted towards medical technology beneath the visionary leadership that embraced research and development. Today, Straumann is a formidable player in the sphere of dental implants, prosthetics, and orthodontic solutions. The company is driven by a simple yet impactful mission: to provide dentists and their patients with the tools and treatments necessary to restore smiles and enhance oral health. Through a robust network of subsidiaries and partners worldwide, Straumann's reach extends to more than 100 countries, facilitating both the manufacturing and distribution of its products on a global scale.
The engine behind the company’s success is its dedication to innovation, customer focus, and education. By investing heavily in R&D, Straumann develops cutting-edge products that address the evolving needs of patients and dental professionals. The company's revenue streams primarily originate from the sale of dental implants, restorative products, and digital equipment, making it a major player in both the premium and value segments of the market. Beyond its product offerings, Straumann thrives by training dental professionals through its comprehensive educational initiatives, ensuring its clients are well-prepared to deliver the highest standard of care. This synergistic approach not only amplifies customer loyalty but also firmly establishes Straumann as a trusted leader in the industry.
Revenue: Straumann reported Q3 revenue of CHF 602 million, up 8.3% organically and 2.9% in reported terms, with strong regional contributions from EMEA and Latin America.
Guidance Reaffirmed: Management confirmed its 2025 outlook for high single-digit organic revenue growth and a 30-60 basis point improvement in core EBIT margin at constant 2024 currency.
Orthodontics Transformation: Strategic partnerships with Smartee and Dental Monitoring will enhance ClearCorrect's value proposition and manufacturing efficiency, aiming to halve ortho operating losses by 2026 and reach breakeven in 2027.
China Slowdown: The company saw a significant slowdown in China due to VBP 2.0 uncertainty, with Q3 described as flattish and Q4 expected to be negative; management remains optimistic for recovery and growth post-implementation.
North America: North America grew 5.7% organically, benefiting from DSO investments, stable patient flows, and strong traction for the iEXCEL implant system.
Tariff Mitigation: Tariff impacts (CHF 20-25 million in 2025 and ~CHF 30 million expected for 2026) are being mitigated by supply chain adjustments, with margin guidance maintained.
Innovation & Digital: New product launches like the SIRIOS X3 scanner and continued digital integration efforts are driving market share gains and customer acquisition.
